Showing 67,361 - 67,370 of 67,637
Persistent link: https://www.econbiz.de/10004990362
Background: Potential differences in toxicity, potency and acquisition price among the liposomal amphotericin B formulations makes it unclear which agent is less costly when total resource consumption and treatment-associated costs are considered. Design: A retrospective cost-minimisation...
Persistent link: https://www.econbiz.de/10004990363
Introduction: Inflammatory bowel disease (IBD) is a chronic condition that afflicts young adults in their economically productive years. The goal of this study was to determine the costs of IBD in Germany from a societal perspective, using cost diaries. Methods: Members of the German Crohn's...
Persistent link: https://www.econbiz.de/10004990364
Persistent link: https://www.econbiz.de/10004990365
DOI: 10.2165/0019053-200826110-00001
Persistent link: https://www.econbiz.de/10004990366
This study uses data from the 1999-2000 SABE survey to analyze socioeconomic inequities in healthcare access, utilization, and quality, for a sample of elderly individuals from Montevideo, Uruguay. We find horizontal inequity favoring the rich in the quality of access to medical visits (lower...
Persistent link: https://www.econbiz.de/10004991450
Between 1997 and 2000 the Australian government introduced three policy reforms that aimed to increase private health insurance coverage and reduce public hospital demand. The first provided income-based tax incentives; the second gave an across-the-board 30% premium subsidy; and the third...
Persistent link: https://www.econbiz.de/10004991588
In The Great Lead Water Pipe Disaster, Werner Troesken looks at a long-running environmental and public health catastrophe: 150 years of lead pipes in local water systems and the associated sickness, premature death, political inaction, and social denial. The harmful effects of lead water pipes...
Persistent link: https://www.econbiz.de/10004991828
Increased health care spending has been argued to be largely due to technological change. Cost-effectiveness analysis is the main tool used by private and public third-party payers to prioritize adoption of the new technologies responsible for this growth. However, such analysis by payers...
Persistent link: https://www.econbiz.de/10004991965
With the aim to understand and estimate the economic impact of outbreaks of community-acquired infections, we performed a review focusing on hepatitis A outbreaks, and retained 13 papers that had collected relevant cost information during such outbreaks. All costs in this article are expressed...
Persistent link: https://www.econbiz.de/10004993637